Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Congress
Main Content

Therapeutic Plenary Session 1102

Management of Advancing Parkinson's Disease

Friday, September 27, 2024
11:00 - 13:00

In this session, the faculty will discuss available therapies for patients with advancing Parkinson’s disease and a holistic approach to the late-stage care of Parkinson’s disease patients.


Chairs:
Maria Rodriguez-Oroz, Spain
Anette Schrag, United Kingdom

Continuous Delivery of Levodopa and Apomorphine
Onanong Phokaewvarangkul, Thailand

DBS and MRgFUS
Maria Fiorella Contarino, Netherlands

Holistic Management of Late-Stage Parkinson's Disease
Janis Miyasaki, Canada

CSPC Liaisons:
Maria Rodriguez-Oroz, Spain

Learning Objectives
At the conclusion of this session, participants should be better able to:

  1. Describe the state-of-the art use of levodopa and apomorphine infusions in Parkinson’s disease
  2. Describe the state-of-the art use of deep brain stimulation and MR-guided focused ultrasound in Parkinson’s disease
  3. Describe a holistic management of late-stage Parkinson’s disease

Recommended Audience
Clinician
Fellow / Resident / Student
Health Professional (non-physician)

Education Level
Beginner / Foundational
Experienced / Intermediate
Expert / Advanced

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice